MedTrace Logo

Effects of Yoga on Children With Cancer

NCT06651918 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2024-10-22

No results posted yet for this study

Summary

This study was planned as a randomized controlled experimental study with a pre-test-post-test design to determine the effect of yoga practice accompanied by a specialist yoga instructor on fatigue, quality of life and symptom control in children diagnosed with cancer between the ages of 8-12.The main questions it aims to answer are:

1. Does yoga practice applied to children diagnosed with cancer reduce fatigue in children?
2. Does yoga practice applied to children diagnosed with cancer affect their quality of life?
3. Does yoga practice applied to children diagnosed with cancer affect the symptoms experienced by children?

Before and after yoga practice, children diagnosed with cancer will answer survey and scale questions about fatigue, quality of life and symptoms.

Conditions

  • Pediatric Cancer

Interventions

BEHAVIORAL

yoga practise

For the experimental study, the researcher will contact the participants to be included in the study and the intervention (yoga group) and control groups will be randomly created. The participants will be informed about the study by the researcher and their voluntary consent will be obtained. The researcher will provide information about the Identifying Characteristics Form for Children Diagnosed with Cancer and Their Families, the Quality of Life Scale for Children (PedsQL) and the Memorial Symptom Assessment Scale to be used in the study. The survey and scales will be applied to each participant individually one day before yoga. Then, the Yoga Group will be applied 3 sessions per week, 3 weeks in a row, each session will be 30 minutes. The researcher will repeat the survey and scale questions that he asked the participants before they started yoga at the end of the 3 weeks.

Sponsors & Collaborators

  • TC Erciyes University

    lead OTHER

Principal Investigators

  • Emine Erdem, Prof. · TC Erciyes University

Study Design

Allocation
RANDOMIZED
Purpose
SCREENING
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
8 Years
Max Age
12 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-01-31
Primary Completion
2025-02-28
Completion
2025-12-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06651918 on ClinicalTrials.gov